Evidence map›Paper›PMID 40115915›Full record

ArticleJournal of gastrointestinal oncology2025

Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features.

Yongfei He, Qiang Gao, Shutian Mo, Ketuan Huang, Yuan Liao, Tianyi Liang, Meifeng Chen, Jicai Wang, Qiang Tao, Guangquan Zhang and 4 more

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yongfei He *Department of Hepatopancreatobiliary Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Qiang Gao *Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Shutian MoDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Ketuan HuangDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuan LiaoDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Tianyi LiangDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Meifeng ChenDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jicai WangDepartment of Hepatopancreatobiliary Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Qiang TaoDepartment of Hepatopancreatobiliary Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Guangquan ZhangDepartment of Hepatopancreatobiliary Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Fenfang WuDepartment of Hepatopancreatobiliary Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Chuangye HanDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xianjie ShiDepartment of Hepatopancreatobiliary Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Tao PengDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Portal hypertension (PHT) is an important factor leading to a poor prognosis in patients with hepatocellular carcinoma (HCC). Identifying patients with PHT for individualized treatment is of great clinical significance. The prediction model of HCC combined PHT is in urgent need of clinical practice. Combining clinical parameters and imaging features can improve prediction accuracy. The application of artificial intelligence algorithms can further tap the potential of data, optimize the prediction model, and provide strong support for early intervention and personalized treatment of PHT. This study aimed to establish a prediction model of PHT based on the clinicopathological features of PHT and computed tomography scanning features of the non-tumor liver area in the portal vein stage. Methods: A total of 884 patients were enrolled in this study, and randomly divided into a training set of 707 patients (of whom 89 had PHT) and a validation set of 177 patients (of whom 23 had PHT) at a ratio of 8:2. Univariate and multivariate logistic regression analyses were performed to screen the clinical features. Radiomics and deep-learning features were extracted from the non-tumorous liver regions. Feature selection was conducted using Results: Portal vein diameter (PVD), Child-Pugh score, and fibrosis 4 (FIB-4) score were identified as independent risk factors for PHT. The predictive model that incorporated clinical features, radiomics features from non-tumorous liver regions, and deep-learning features had an area under the curve (AUC) of 0.966 [95% confidence interval (CI): 0.954-0.979] and a sensitivity of 0.966 in the training set, and an AUC of 0.698 (95% CI: 0.565-0.831) and a sensitivity of 0.609 in the validation set. Conclusions: The preoperative evaluation showed that increased PVD, higher Child-Pugh score, and increased FIB-4 score were independent risk factors for PHT in patients with HCC. To predict the occurrence of PHT more effectively, we construct a comprehensive prediction model. The model incorporates clinical parameters, radiomic features, and deep learning features. This fusion of multi-modal features enables the model to capture complex information related to PHT more comprehensively, thus achieving high prediction accuracy and practicability.

Indexed as

deep learningHepatocellular carcinoma (HCC)portal hypertension (PHT)prediction modelradiomics

Identifiers

PMID40115915
PMCPMC11921233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.